It's rare when one investment bank upgrades another financial institution, and that took place on Monday when Goldman Sachs upgraded Wells Fargo & Co (NYSE: WFC) m
It seems that every day investors get a warning sign the Federal Reserve's efforts to slow down consumer spending and the entire economy is coming to fruition.
Going back to at least December 2014, Biogen Inc (NASDAQ: BIIB) has been diligently working on drugs to cure Alzheimer's disease. Both the negative and positive data revealed over the years have instigated wild price gyrations in the issue.
Let”s cut to the chase. Long before the Fed heads made their hawkish comments Tuesday morning, we all knew what is plaguing this market: rising interest rates.
One old market adage that is commonly mentioned just ahead of the Jewish holidays is "Sell Rosh Hashanah, Buy Yom Kippur." With the holidays commencing Sunday at sundown, it is time for this year's investment interpretation of the adage from the perspective of this investor.
There are good days and bad days to be announcing earnings. When the market is good, investors are in buying mode. When the market has a bad day, investors do not have the same appetite for risk. As of Thursday afternoon, the markets are leaning to the downside.
When a company's computer systems are compromised, it is not surprising there is going to be a negative impact on its share price, though the price action following such an announcement can vary.